Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-07-17

MannKind (MNKD)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$9,300,485
Michael Castagna total, FY2025
50th
CEO pay percentile vs peers
46:1
CEO-to-median pay ratio
89.39%
Say-on-pay support, latest vote
Companies that benchmark against MNKD
7 companies name MNKD as a compensation peer

Each company listed discloses MNKD in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named MNKD in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Michael Castagna$789,436$0$7,689,480$0$675,757$0$145,812$9,300,485
Chief Executive Officer
Dominic Marasco447,59606,269,0150239,464024,3976,980,472
President, Endocrine Business Unit
David Thomson520,74802,133,4800378,6000122,4203,155,248
Executive Vice President, General Counsel and Secretary
Stuart Tross438,70902,133,4800234,7090138,7972,945,695
Executive Vice President, Human Resources
Christopher Prentiss470,08502,133,4800251,495031,7392,886,799
Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Michael Castagna$9,300,485
Dominic Marasco6,980,472
David Thomson3,155,248
Stuart Tross2,945,695
Christopher Prentiss2,886,799

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Christopher PrentissChief Financial Officer2026-04-22D12,267$3$33,612CommonForm 4 ↗
Steven B. BinderDirector2026-05-11D16,940355,733CommonForm 4 ↗
Michael CastagnaDirector2026-05-11D34,9574123,049CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-05-11D3,03339,979CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-05-11D8,073428,417CommonForm 4 ↗
Steven B. BinderDirector2026-05-11D5,560419,571CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-05-11D12,387443,602CommonForm 4 ↗
Christine MundkurDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Steven B. BinderDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Anthony HooperDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Dominic MarascoPres, Endocrine Business Unit2026-05-20A8,474324,998CommonForm 4 ↗
Ronald J. ConsiglioDirector2026-05-20A16,55600Derivative, Class A CommonForm 4 ↗
James S. ShannonDirector2026-05-20A16,55600Derivative, Class A CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-05-20A33,898399,999CommonForm 4 ↗
Jennifer GrancioDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Michael A. FriedmanDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Ronald J. ConsiglioDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Anthony HooperDirector2026-05-20A16,55600Derivative, Class A CommonForm 4 ↗
Sabrina KayDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
Ronald J. ConsiglioDirector2026-05-20A10,000329,500CommonForm 4 ↗
James S. ShannonDirector2026-05-20A82,78100Derivative, Class A CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15A93,79000CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15D93,79000Derivative, Class A CommonForm 4 ↗
Steven B. BinderDirector2026-07-15D4,073416,659CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D93,79000Derivative, Class A CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15D8,253433,755CommonForm 4 ↗
Michael CastagnaDirector2026-07-15D63,9964261,744CommonForm 4 ↗
Steven B. BinderDirector2026-07-15D15,688464,164CommonForm 4 ↗
Steven B. BinderDirector2026-07-15D52,4854213,089CommonForm 4 ↗
Michael CastagnaDirector2026-07-15A350,26000CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15D12,331450,434CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15A70,55000CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15D5,372421,971CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D12,662451,788CommonForm 4 ↗
Steven B. BinderDirector2026-07-15A93,79000CommonForm 4 ↗
Dominic MarascoPres, Endocrine Business Unit2026-07-15D3,623414,818CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15D11,572447,329CommonForm 4 ↗
Steven B. BinderDirector2026-07-15D4,634418,953CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15D22,047490,172CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15D70,55000Derivative, Class A CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D24,109497,641CommonForm 4 ↗
Christopher PrentissChief Financial Officer2026-07-15D11,572447,329CommonForm 4 ↗
Christopher PrentissChief Financial Officer2026-07-15D10,675443,661CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15A93,79000CommonForm 4 ↗
Stuart TrossChief People & Workpl Officer2026-07-15D33,6524137,637CommonForm 4 ↗
Michael CastagnaDirector2026-07-15D192,8194788,630CommonForm 4 ↗
Michael CastagnaDirector2026-07-15D47,4814194,197CommonForm 4 ↗
Michael CastagnaDirector2026-07-15D58,9044240,917CommonForm 4 ↗
Michael CastagnaDirector2026-07-15D350,26000Derivative, Class A CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15D10,079441,223CommonForm 4 ↗
Sanjay R. SinghEVP Technical Operations2026-07-15D9,297438,025CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D51,6324211,175CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D17,754472,614CommonForm 4 ↗
David ThomsonEVP Genl Counsel & Secretary2026-07-15D16,378466,986CommonForm 4 ↗
Steven B. BinderDirector2026-07-15D93,79000Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Christopher PrentissPRSU$2,133,480
Dominic MarascoPRSU6,269,015
Stuart TrossPRSU2,133,480
David ThomsonPRSU2,133,480
Michael CastagnaPRSU7,689,480
03b

Vehicle mix — grant-date fair value by award type

Grant-level vehicle detail not disclosed.

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Stuart TrossPSU145,000$822,150
David ThomsonPSU113,000640,710
Dominic MarascoRSU59,500337,365
Michael CastagnaRSU348,7501,977,413
Stuart TrossRSU46,000260,820
David ThomsonRSU46,000260,820
Christopher PrentissRSU103,600587,412
Michael CastagnaPSU523,0002,965,410
Michael CastagnaPSU422,0002,392,740
Michael CastagnaPSU569,0003,226,230
Michael CastagnaRSU428,0002,426,760
Christopher PrentissPSU158,000895,860
Michael CastagnaRSU63,500360,045
Dominic MarascoPSU1,000,0005,670,000
Dominic MarascoPSU72,500411,075
Stuart TrossPSU158,000895,860
David ThomsonPSU145,000822,150
David ThomsonPSU158,000895,860
Christopher PrentissPSU145,000822,150
Christopher PrentissRSU119,000674,730
Christopher PrentissRSU96,750548,573
David ThomsonRSU22,500127,575
David ThomsonRSU119,000674,730
Stuart TrossRSU119,000674,730
Stuart TrossPSU113,000640,710
Stuart TrossRSU96,750548,573
David ThomsonRSU96,750548,573
Stuart TrossRSU22,500127,575
Dominic MarascoRSU252,0001,428,840
Michael CastagnaRSU172,500978,075
05

Incentive-plan design — the Compensation Discussion & Analysis

This philosophy is to provide compensation and benefits programs designed to attract, engage, and retain a high caliber workforce that enables us to compete with companies in the pharmaceutical and biotechnology industries and to reward individual and corporate performance.

CEO STI target (% of salary)80%
CEO LTI target (% of salary)
Independent consultantMercer LLC
Clawback policyTrue
Anti-hedgingtrue
Anti-pledgingfalse
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-05-20137,332,41816,295,1381,303,49789.39%Passed
20252025-05-14131,379,08211,526,7931,338,68391.93%Passed
20242024-05-15112,281,51711,612,5281,260,65489.71%Passed
20232023-05-25113,431,64711,361,3021,048,61690.9%Passed
20222022-05-1078,653,5649,044,5011,224,14888.45%Passed
20212021-05-2083,582,1347,850,0951,293,44190.14%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-05-2089.39%a
20252025-05-1491.93%b
20242024-05-1589.71%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Approved under the standard stated in the filing — “Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the same effect as "Against" votes.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)46 : 1
CEO total compensation$9,300,485
Median employee compensation$203,592
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
James S. ShannonIndependent · Board Chair · Compensation$80,000$241,543$0$0$0$321,543
Ronald J. ConsiglioIndependent · Audit (Chair) · Nominating and Corporate Governance80,000241,543000321,543
Anthony HooperIndependent · Compensation (Chair) · Audit · Newly elected30,000289,852000319,852
Jennifer GrancioIndependent · Nominating and Corporate Governance (Chair) · Audit70,000241,543000311,543
Sabrina KayIndependent · Compensation · Audit · Newly elected17,500289,852000307,352
Christine MundkurIndependent · Audit · Nominating and Corporate Governance65,000241,543000306,543
Michael A. FriedmanIndependent · Nominating and Corporate Governance55,000241,543000296,543
Steven B. BinderNot independent50,000241,543000291,543
Michael E. CastagnaEmployee director00000
09

Board fee structure and ownership guideline

Annual cash retainer$50,000
Annual equity retainer$241,543
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)25,000 / 25,000 / 10,000
Stock ownership guideline
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$447,500
Equity awards (grant-date value)$2,028,962
All other compensation$0
Total cost of the board$2,476,462

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies MannKind names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including MannKind.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1ADMA Biologics, Inc.2025Adam Grossman$925,000$4,049,994$4,049,998$1,156,250$10,237,326
2MannKind2025Michael Castagna789,4367,689,4800675,7579,300,485
3Travere Therapeutics, Inc.2025Eric Dube854,2503,314,5203,309,384964,1258,457,151

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
MannKind107%PSU 55 · RSU 45Yes — Total Stockholder Return (TSR) relative to Russell 3000 Pharmaceutical & Biotechnology IndexMercer LLC
ADMA Biologics, Inc.125%RSU 50 · Options 50not disclosedPay Governance LLC
Travere Therapeutics, Inc.150%not disclosedNoAon

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Michael CastagnaDEF 14A2026-04-070001193125-26-145613Section “Compensation Table”. As printed: 9,300,485. Filing ↗machine: t24 · r5 · c27 · span 606612–606621
2Section 01, Dominic MarascoDEF 14A2026-04-070001193125-26-145613Section “Compensation Table”. As printed: 6,980,472. Filing ↗machine: t24 · r12 · c27 · span 673006–673015
3Section 01, David ThomsonDEF 14A2026-04-070001193125-26-145613Section “Compensation Table”. As printed: 3,155,248. Filing ↗machine: t24 · r15 · c27 · span 698680–698689
4Section 01, Stuart TrossDEF 14A2026-04-070001193125-26-145613Section “Compensation Table”. As printed: 2,945,695. Filing ↗machine: t24 · r19 · c27 · span 736983–736992
5Section 01, Christopher PrentissDEF 14A2026-04-070001193125-26-145613Section “Compensation Table”. As printed: 2,886,799. Filing ↗machine: t24 · r9 · c27 · span 644922–644931
6Section 03, Christopher Prentiss PRSUDEF 14A2026-04-070001193125-26-145613Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t24 · r9 · c12 · span 639729–639738
7Section 03, Dominic Marasco PRSUDEF 14A2026-04-070001193125-26-145613Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t24 · r12 · c12 · span 667815–667824
8Section 03, Stuart Tross PRSUDEF 14A2026-04-070001193125-26-145613Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t24 · r19 · c12 · span 731751–731760
9Section 03, David Thomson PRSUDEF 14A2026-04-070001193125-26-145613Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t24 · r15 · c12 · span 693487–693496
10Section 03, Michael Castagna PRSUDEF 14A2026-04-070001193125-26-145613Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t24 · r5 · c12 · span 601417–601426
11Section 07, pay ratioDEF 14A2026-04-070001193125-26-145613Section “CEO Pay Ratio”. As printed: 46 : 1. Filing ↗machine: span 1491900–1491902
12Section 08, James S. ShannonDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 321,543. Filing ↗
13Section 08, Ronald J. ConsiglioDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 321,543. Filing ↗machine: t14 · r3 · c8 · span 313189–313196
14Section 08, Anthony HooperDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 319,852. Filing ↗machine: t14 · r6 · c8 · span 323832–323839
15Section 08, Jennifer GrancioDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 311,543. Filing ↗machine: t14 · r5 · c8 · span 320284–320291
16Section 08, Sabrina KayDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 307,352. Filing ↗machine: t14 · r7 · c8 · span 327377–327384
17Section 08, Christine MundkurDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 306,543. Filing ↗machine: t14 · r8 · c8 · span 330924–330931
18Section 08, Michael A. FriedmanDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 296,543. Filing ↗machine: t14 · r4 · c8 · span 316738–316745
19Section 08, Steven B. BinderDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 291,543. Filing ↗machine: t14 · r2 · c8 · span 309640–309647
20Section 08, Michael E. CastagnaDEF 14A2026-04-070001193125-26-145613Section “Director Compensation”. As printed: 0. Filing ↗
21Section 02, Christopher Prentiss 2026-04-22Form 42026-04-240001193125-26-178298Insider equity transaction reported since the proxy statement. Filing ↗
22Section 02, Steven B. Binder 2026-05-11Form 42026-05-130001193125-26-222311Insider equity transaction reported since the proxy statement. Filing ↗
23Section 02, Michael Castagna 2026-05-11Form 42026-05-130001193125-26-222309Insider equity transaction reported since the proxy statement. Filing ↗
24Section 02, David Thomson 2026-05-11Form 42026-05-130001193125-26-222310Insider equity transaction reported since the proxy statement. Filing ↗
25Section 02, Stuart Tross 2026-05-11Form 42026-05-130001193125-26-222312Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Steven B. Binder 2026-05-11Form 42026-05-130001193125-26-222311Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, David Thomson 2026-05-11Form 42026-05-130001193125-26-222310Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, Christine Mundkur 2026-05-20Form 42026-05-220001193125-26-237426Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Steven B. Binder 2026-05-20Form 42026-05-220001193125-26-237438Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Anthony Hooper 2026-05-20Form 42026-05-220001193125-26-237431Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Dominic Marasco 2026-05-20Form 42026-05-220001193125-26-237428Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Ronald J. Consiglio 2026-05-20Form 42026-05-220001193125-26-237444Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, James S. Shannon 2026-05-20Form 42026-05-220001193125-26-237430Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Stuart Tross 2026-05-20Form 42026-05-220001193125-26-237429Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Jennifer Grancio 2026-05-20Form 42026-05-220001193125-26-237432Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Michael A. Friedman 2026-05-20Form 42026-05-220001193125-26-237456Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Ronald J. Consiglio 2026-05-20Form 42026-05-220001193125-26-237444Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Anthony Hooper 2026-05-20Form 42026-05-220001193125-26-237431Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Sabrina Kay 2026-05-20Form 42026-05-220001193125-26-237424Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Ronald J. Consiglio 2026-05-20Form 42026-05-220001193125-26-237444Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, James S. Shannon 2026-05-20Form 42026-05-220001193125-26-237430Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Dominic Marasco 2026-07-15Form 42026-07-170001193125-26-308137Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Christopher Prentiss 2026-07-15Form 42026-07-170001193125-26-308139Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Christopher Prentiss 2026-07-15Form 42026-07-170001193125-26-308139Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Stuart Tross 2026-07-15Form 42026-07-170001193125-26-308134Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Michael Castagna 2026-07-15Form 42026-07-170001193125-26-308133Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Sanjay R. Singh 2026-07-15Form 42026-07-170001193125-26-308132Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, David Thomson 2026-07-15Form 42026-07-170001193125-26-308131Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Steven B. Binder 2026-07-15Form 42026-07-170001193125-26-308129Insider equity transaction reported since the proxy statement. Filing ↗
76Section 06, 2026 voteForm 8-K2026-05-220001193125-26-237183Item 5.07 · say-on-pay result. As reported: 89.39% (votes for as printed: 137,332,418). Filing ↗
77Section 06, 2025 voteForm 8-K2025-05-190000950170-25-074523Item 5.07 · say-on-pay result. As reported: 91.93% (votes for as printed: 131,379,082). Filing ↗
78Section 06, 2024 voteForm 8-K2024-05-160000950170-24-061164Item 5.07 · say-on-pay result. As reported: 89.71% (votes for as printed: 112,281,517). Filing ↗
79Section 09b board cost (computed)ComputedcomputedCash 447,500 + equity 2,028,962 + all other 0 = 2,476,462, summed across the director compensation table rows.machine: formula: Σ = 2,476,462
80ADMA Biologics, Inc., Section 10b CEO totalDEF 14A2026-04-150001140361-26-014799CEO total compensation as printed in ADMA Biologics, Inc.'s own proxy. As printed: 10,237,326. Filing ↗machine: r2 · c25 · span 619659–619670
81MannKind (subject), Section 10b CEO totalDEF 14A2026-04-070001193125-26-145613CEO total compensation as printed in MannKind's own proxy. As printed: 9,300,485. Filing ↗machine: t24 · r5 · c27 · span 606612–606621
82Travere Therapeutics, Inc., Section 10b CEO totalDEF 14A2026-04-060001438533-26-000027CEO total compensation as printed in Travere Therapeutics, Inc.'s own proxy. As printed: 8,457,151. Filing ↗machine: span 558514–558523
83Section 10a, Travere Therapeutics, Inc. reciprocityDEF 14A0001438533-26-000027Travere Therapeutics, Inc.'s most recent proxy was read; its disclosed peer group does not include MannKind. Filing ↗
84Section 10a, ADMA Biologics, Inc. reciprocityDEF 14A0001140361-26-014799ADMA Biologics, Inc. names MannKind in its own disclosed peer group (read from its most recent proxy). Filing ↗